Close Menu
Home » iCubate Receives CE Mark for Dx Platform, Bloodstream Infection Assay

iCubate Receives CE Mark for Dx Platform, Bloodstream Infection Assay

Aug 23, 2017
|
staff reporter

NEW YORK (GenomeWeb) – iCubate announced yesterday that it has received CE mark for its first clinical assay, the iC-GPC assay and its platform, the iC-System, used for the rapid diagnosis of pathogenic bacteria associated with bloodstream infection. The CE mark provides an entry for iCubate to begin market integration into the European Union.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From the Depths

Researchers have sequenced the genome of the depth-dwelling giant squid.

Not the Research Topic

Prosecutors have charged a former Drexel University professor with theft for allegedly spending federal grant money on adult entertainment and other unrelated expenses, according to the Philadelphia Inquirer.

 

Prison in Insider Trading Case

Chris Collins, a former US representative, has been sentenced to more than two years in prison in an insider trading case involving an Australian biotechnology firm, the New York Times reports.

PNAS Papers on Trypanosoma brucei Transcripts, Inherited Retinal Disease, Gut Microbiome Development

In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.

What's Popular?

In Companion Diagnostics

  1. Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in Prostate Cancer

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.